ATE255109T1 - Imidazopyridinderivate als gaba rezeptor liganden - Google Patents

Imidazopyridinderivate als gaba rezeptor liganden

Info

Publication number
ATE255109T1
ATE255109T1 AT00956700T AT00956700T ATE255109T1 AT E255109 T1 ATE255109 T1 AT E255109T1 AT 00956700 T AT00956700 T AT 00956700T AT 00956700 T AT00956700 T AT 00956700T AT E255109 T1 ATE255109 T1 AT E255109T1
Authority
AT
Austria
Prior art keywords
receptor ligands
gaba receptor
imidazopyridine derivatives
derivatives
imidazopyridine
Prior art date
Application number
AT00956700T
Other languages
English (en)
Inventor
David James Hallett
Michael Rowley
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Application granted granted Critical
Publication of ATE255109T1 publication Critical patent/ATE255109T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Exhaust Gas Treatment By Means Of Catalyst (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
AT00956700T 1999-09-07 2000-08-30 Imidazopyridinderivate als gaba rezeptor liganden ATE255109T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9921150.0A GB9921150D0 (en) 1999-09-07 1999-09-07 Therapeutic agents
PCT/GB2000/003350 WO2001018000A1 (en) 1999-09-07 2000-08-30 Imidazo-pyridine derivatives as ligands for gaba receptors

Publications (1)

Publication Number Publication Date
ATE255109T1 true ATE255109T1 (de) 2003-12-15

Family

ID=10860524

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00956700T ATE255109T1 (de) 1999-09-07 2000-08-30 Imidazopyridinderivate als gaba rezeptor liganden

Country Status (10)

Country Link
US (1) US6723735B1 (de)
EP (1) EP1214319B1 (de)
JP (1) JP2003508530A (de)
AT (1) ATE255109T1 (de)
AU (1) AU776815B2 (de)
CA (1) CA2384048A1 (de)
DE (1) DE60006835T2 (de)
ES (1) ES2209963T3 (de)
GB (1) GB9921150D0 (de)
WO (1) WO2001018000A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077605A1 (en) * 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
EP1854798A3 (de) * 2000-09-19 2007-11-28 Bristol-Myers Squibb Company Kondensierte heterozyklische Succinimid-Verbindungen und Analoga daraus, Modulatoren der nuklearen Hormonrezeptorfunktion
GB0117277D0 (en) 2001-07-16 2001-09-05 Merck Sharp & Dohme Therapeutic agents
PA8535601A1 (es) 2000-12-21 2002-11-28 Pfizer Derivados benzimidazol y piridilimidazol como ligandos para gabaa
US20040087548A1 (en) 2001-02-27 2004-05-06 Salvati Mark E. Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
EP1467979B1 (de) * 2001-12-19 2008-08-13 Bristol-Myers Squibb Company Kondensierte heterocyclische verbindungen und deren analoga; modulatoren der funktion von nukleären hormonrezeptoren
GB0208392D0 (en) * 2002-04-11 2002-05-22 Merck Sharp & Dohme Therapeutic compounds
WO2007025177A2 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258359A3 (de) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenese durch Modulation des Muscarinrezeptors mit Sabcomelin
EP2377530A3 (de) 2005-10-21 2012-06-20 Braincells, Inc. Modulation von Neurogenese durch PDE-Hemmung
EP1942879A1 (de) * 2005-10-31 2008-07-16 Braincells, Inc. Gaba-rezeptor-vermittelte modulation von neurogenese
US7465795B2 (en) 2005-12-20 2008-12-16 Astrazeneca Ab Compounds and uses thereof
WO2007073283A1 (en) 2005-12-20 2007-06-28 Astrazeneca Ab Substituted cinnoline derivatives as gabaa-receptor modulators and method for their synthesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2021000A2 (de) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenese mittels angiotensin-modulation
MX2008014320A (es) 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
BRPI0716604A2 (pt) 2006-09-08 2013-04-09 Braincells Inc combinaÇÕes contendo um derivado de 4-acilaminopiridina
US8895745B2 (en) 2006-12-22 2014-11-25 Astex Therapeutics Limited Bicyclic heterocyclic compounds as FGFR inhibitors
CA2672213C (en) 2006-12-22 2016-02-16 Astex Therapeutics Limited Bicyclic amine derivatives as protein tyrosine kinase inhibitors
TW200911803A (en) * 2007-07-16 2009-03-16 Organon Nv 6-phenyl-1H-imidazo [4,5-c] pyridine-4-carbonitrile derivatives
GB0720038D0 (en) 2007-10-12 2007-11-21 Astex Therapeutics Ltd New compounds
GB0720041D0 (en) 2007-10-12 2007-11-21 Astex Therapeutics Ltd New Compounds
ES2399175T3 (es) * 2008-04-29 2013-03-26 Novartis Ag Derivados de imidazo-piridina como inhibidores de quinasa del receptor tipo activina (alk4 o alk5)
GB0810902D0 (en) 2008-06-13 2008-07-23 Astex Therapeutics Ltd New compounds
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
GB0906472D0 (en) 2009-04-15 2009-05-20 Astex Therapeutics Ltd New compounds
GB0906470D0 (en) 2009-04-15 2009-05-20 Astex Therapeutics Ltd New compounds
CA2951497C (en) * 2014-06-12 2019-04-09 Pfizer Limited Imidazopyridazine derivatives as modulators of the gabaa receptor activity
HUE060943T2 (hu) 2018-09-13 2023-04-28 Saniona As A gaba A receptor ligandum
WO2025141131A1 (en) 2023-12-27 2025-07-03 Saniona A/S A gabaa receptor ligand and the use thereof in medicine, in particular in the treatment of epilepsy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK40192D0 (da) * 1992-03-26 1992-03-26 Neurosearch As Imidazolforbindelser, deres fremstilling og anvendelse
AU675484B2 (en) 1993-03-24 1997-02-06 Neurosearch A/S Benzimidazole compounds, their use and preparation
GB9702524D0 (en) * 1997-02-07 1997-03-26 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
EP1214319A1 (de) 2002-06-19
AU776815B2 (en) 2004-09-23
WO2001018000A1 (en) 2001-03-15
EP1214319B1 (de) 2003-11-26
JP2003508530A (ja) 2003-03-04
ES2209963T3 (es) 2004-07-01
AU6856700A (en) 2001-04-10
DE60006835T2 (de) 2004-09-02
CA2384048A1 (en) 2001-03-15
US6723735B1 (en) 2004-04-20
GB9921150D0 (en) 1999-11-10
DE60006835D1 (de) 2004-01-08

Similar Documents

Publication Publication Date Title
ATE255109T1 (de) Imidazopyridinderivate als gaba rezeptor liganden
DE69936998D1 (de) Pyrazolotriazinderivate als gaba-rezeptorliganden
ATE270672T1 (de) Imidazopyridinderivate als liganden für gaba- rezeptoren
WO2002002557A3 (en) 2-phenylimidazo[1,2-a]pyridine derivatives: a new class of gaba brain receptor ligands
TR199700749T1 (xx) 5-HT resept�r antagonisti olarak indole t�revleri.
YU51703A (sh) Derivati benzimidazola i piridilimidazola kao veznici za gaba receptore
NO990304L (no) Substituerte triazol-pyridazolderivater som ligander for GABA reseptorer
TR200400702T4 (tr) AMP özgü fosfodiesteraz inhibtörleri olarak 3-tiazol-4-il-pirolidin türevleri.
MXPA04000372A (es) Compuesto biciclicos de heteroarilo fusionados sustituidos con heteroarilo como ligandos del receptor gabaa.
DE60001983T2 (de) Bicyclische und tricyclische heteroaromatische verbindungen
DE60232029D1 (de) N-ä1h-indol-5-ylünaphthalin-1-sulphonamid-derivate und verwandte verbindungen als serotonin 5-ht6 rezeptor antagonisten zur behandlung von erkrankungen des zentralen nervensystems
DE60016566D1 (de) Triazolopyridazinderivate als liganden für gaba-rezeptoren
MA30631B1 (fr) Inhibiteurs de tyrosine kinase
ATE247639T1 (de) Arylsubstituierte cyclische amine als selektive dopamin-d3-liganden
EA200000783A1 (ru) Производные триазолопиридазина в качестве лигандов для гамк рецепторов
ATE335741T1 (de) 8-fluorimidazo(1,2-a)pyridin derivative als liganden für gaba rezeptoren
ATE247652T1 (de) 4-substituierte chinolinderivate als nk-3 und/oder gaba(a) rezeptor liganden
ATE253066T1 (de) Imidazotriazinderivate als gaba rezeptor-liganden
MA29643B1 (fr) Benzocycloheptapyridines comme inhibiteurs du recepteur tyrozine kinase met
ATE250062T1 (de) Triazolopiridazinederivate als gaba rezeptor- liganden
PT1023291E (pt) Derivados de dipiridoimidazole uteis no tratamento de desordens do sistema nervoso central
NO994527L (no) 2,3-dihydrofuro[3,2-b]pyridin, dets fremstilling og anvendelse derav i terapi
DE69907448D1 (de) Pyrido[2,3-b]indolizinderivate und aza analoge: crf1 spezifische liganden
ATE359269T1 (de) 4-arylsulphonylpiperidin-derivate als 5-ht2a - rezeptor antagonisten
ATE321044T1 (de) C-6 ringsubstituierte pyrido(1,2- a)benzimidazolderivate zur behandlung von störungen des zentralen nervensystems

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties